This report highlights all changes (additions and deletions) to the cvs caremark prescribing guide
Report Effective 10-01-2013 (Standard Drug List Reflects Removals)
This report highlights all changes (additions and deletions) to the CVS Caremark Performance Drug List. ADDITIONS: Therapeutic Category/ Subcategory Indication Alternatives/Comments Brand Agents: Flovent Diskus
To provide an additional inhaled corticosteroid therapy
option for patients four years of age and older.
Flovent Diskus was added to the Performance Drug List
in the adjudication systems on 09/1/2013.
• Treatment of asthma for patients requiring oral corticosteroid therapy.
Flovent HFA
To provide an additional non-CFC inhaled corticosteroid
therapy option for patients four years of age and older.
Flovent HFA was added to the Performance Drug List in
• Treatment of asthma for patients requiring oral corticosteroid therapy.
Invokana
To provide an additional therapy option that provides a
representative in a new drug class to treat type 2
Sodium-Glucose improve glycemic control in adults
This document contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with CVS Caremark. The information contained in this document is proprietary. The information may not be copied in whole or in part without written permission. 2013 Caremark Rx, L.L.C. All rights reserved. 106-28758b 072413
Report Effective 10-01-2013 (Standard Drug List Reflects Removals) Therapeutic Category/ Subcategory Indication Alternatives/Comments Locoid Lotion
Topical/ Locoid Lotion is indicated for the
To provide an additional medium potency topical
Zomig Nasal Spray
g Nasal Spray is indicated for To provide a nasal spray therapy option for the treatment
Zomig (zolmitriptan) will be replaced on the Performance Drug List by the “A”-rated generic zolmitriptan tablets and orally disintegrating tablets. Zomig Nasal Spray (zolmitriptan) remains preferred on the drug list.
Generic Agents: candesartan
Cardiovascular/ Candesartan is indicated for:
To provide an additional generic therapy option.
• Treatment of heart failure (New York Heart Association [NYHA] class II to IV).
candesartan/
Cardiovascular/ Candesartan/hydrochlorothiazide
To provide an additional generic therapy option.
hydrochloro-
This document contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with CVS Caremark. The information contained in this document is proprietary. The information may not be copied in whole or in part without written permission. 2013 Caremark Rx, L.L.C. All rights reserved. 106-28758b 072413
Report Effective 10-01-2013 (Standard Drug List Reflects Removals) Therapeutic Category/ Subcategory Indication Alternatives/Comments thiazide trospium
Genitourinary/ Trospium extended release is
To provide an additional generic therapy option.
extended release
overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
zolmitriptan
To provide additional generic therapy options.
for the acute treatment of migraine The “A”-rated generic zolmitriptan tablets and orally
disintegrating tablets will replace the branded agent
Zomig (zolmitriptan) tablets and Zomig-ZMT (zolmitriptan) orally disintegrating tablets on the Performance Drug List.
DELETIONS: Therapeutic Category/ Subcategory Indication Alternatives/Comments Brand Agents: Zomig
Availability of additional generic therapy options.
Migraine/ i ndicated for the acute treatment
This document contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with CVS Caremark. The information contained in this document is proprietary. The information may not be copied in whole or in part without written permission. 2013 Caremark Rx, L.L.C. All rights reserved. 106-28758b 072413
Report Effective 10-01-2013 (Standard Drug List Reflects Removals) Therapeutic Category/ Subcategory Indication Alternatives/Comments
Zomig (zolmitriptan) tablets and Zomig-ZMT (zolmitriptan)
orally disintegrating tablets will be replaced on the
Performance Drug List by the “A”-rated generic zolmitriptan tablets and orally disintegrating tablets. Zomig Nasal Spray (zolmitriptan) will also be listed on the Performance Drug List.
This document contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with CVS Caremark. The information contained in this document is proprietary. The information may not be copied in whole or in part without written permission. 2013 Caremark Rx, L.L.C. All rights reserved. 106-28758b 072413
W O U N D C A R E Wound Care of a Diabetic Foot Ulcer Tom Wynn, RPh narrowing of the blood vessels in the feet and legs. Poor circu-lation in combination with the high-pressure areas on the bot- Chad Thompson, PharmD tom of the foot can lead to callous formation in the patientwho has diabetes. If not addressed, the callous can lead to anulcer. The final stage can be gangrene o
TAKEDA IRELAND Lean Manufacturing as a Strategy, Paperless Manufacturing as a Result. Takeda Pharmaceutical Company (TPC) Limited is a dynamic and growing Japanese pharmaceutical company that is committed to improving the health and quality of life of people around the world. Employing 14,500 people worldwide, Takeda is number one pharmaceutical in Japan and one of the world's top 100 com
Report 
Report 
Report 
Report